These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 26526233)

  • 21. Fibulin-5 is a tumour suppressor inhibiting cell migration and invasion in ovarian cancer.
    Heo JH; Song JY; Jeong JY; Kim G; Kim TH; Kang H; Kwon AY; An HJ
    J Clin Pathol; 2016 Feb; 69(2):109-16. PubMed ID: 26251522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteolytic Targeting Chimeras with Specificity for Plasma Membrane and Intracellular Estrogen Receptors.
    Lu AS; Rouhimoghadam M; Arnatt CK; Filardo EJ; Salem AK
    Mol Pharm; 2021 Mar; 18(3):1455-1469. PubMed ID: 33600191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
    Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
    Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW; Leung PC; Wong AS
    Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen-independent role of ERα in ovarian cancer progression induced by leptin/Ob-Rb axis.
    Ghasemi A; Saeidi J; Mohtashami M; Hashemy SI
    Mol Cell Biochem; 2019 Aug; 458(1-2):207-217. PubMed ID: 31077012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibitory effects of matrix metalloproteinase (MMP) inhibitor LY52 on expression of MMP-2 and MMP-9 and invasive ability of human ovarian carcinoma cell line SKOV3].
    Yuan YX; Xu WF; Liu J; Chen MH; Meng H; Qu XJ
    Ai Zheng; 2006 Jun; 25(6):663-70. PubMed ID: 16764758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor-I regulates GPER expression and function in cancer cells.
    De Marco P; Bartella V; Vivacqua A; Lappano R; Santolla MF; Morcavallo A; Pezzi V; Belfiore A; Maggiolini M
    Oncogene; 2013 Feb; 32(6):678-88. PubMed ID: 22430216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of G protein-coupled estrogen receptor-1, matrix metalloproteinases 2 and 9, and heparin binding epidermal growth factor-like growth factor in estradiol-17β-stimulated bovine satellite cell proliferation.
    Kamanga-Sollo E; Thornton KJ; White ME; Dayton WR
    Domest Anim Endocrinol; 2014 Oct; 49():20-6. PubMed ID: 25010024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo.
    Guo F; Tian J; Cui M; Fang M; Yang L
    Mol Med Rep; 2015 Jul; 12(1):753-9. PubMed ID: 25738807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer.
    Hojnik M; Sinreih M; Anko M; Hevir-Kene N; Knific T; Pirš B; Grazio SF; Rižner TL
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Breast Cancer Inhibitors Specific for G Protein-Coupled Estrogen Receptor (GPER)-Expressing Cells.
    Aiello F; Carullo G; Giordano F; Spina E; Nigro A; Garofalo A; Tassini S; Costantino G; Vincetti P; Bruno A; Radi M
    ChemMedChem; 2017 Aug; 12(16):1279-1285. PubMed ID: 28520140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
    Zekas E; Prossnitz ER
    BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long Noncoding RNA MIR4697HG Promotes Cell Growth and Metastasis in Human Ovarian Cancer.
    Zhang LQ; Yang SQ; Wang Y; Fang Q; Chen XJ; Lu HS; Zhao LP
    Anal Cell Pathol (Amst); 2017; 2017():8267863. PubMed ID: 28168162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro.
    Chen L; Liu T; Zhang S; Zhou J; Wang Y; Di W
    J Ovarian Res; 2014 Dec; 7():115. PubMed ID: 25491408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression.
    Santolla MF; Vivacqua A; Lappano R; Rigiracciolo DC; Cirillo F; Galli GR; Talia M; Brunetti G; Miglietta AM; Belfiore A; Maggiolini M
    Cells; 2019 Mar; 8(3):. PubMed ID: 30866584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
    Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival.
    Schüler-Toprak S; Skrzypczak M; Ignatov T; Ignatov A; Ortmann O; Treeck O
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3175-3188. PubMed ID: 32813115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. G-protein-coupled estrogen receptor suppresses the migration of osteosarcoma cells via post-translational regulation of Snail.
    Wang Z; Chen X; Zhao Y; Jin Y; Zheng J
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):87-96. PubMed ID: 30341688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer.
    Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY
    J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.